{"id":201,"date":"2026-03-31T18:42:21","date_gmt":"2026-03-31T09:42:21","guid":{"rendered":"https:\/\/site.convention.co.jp\/jspho2026\/?page_id=201"},"modified":"2026-04-01T10:03:12","modified_gmt":"2026-04-01T01:03:12","slug":"abstracts-en","status":"publish","type":"page","link":"https:\/\/site.convention.co.jp\/jspho2026\/abstracts-en\/","title":{"rendered":"Call for Abstract"},"content":{"rendered":"
\t\t\t

This page is for overseas participants only.
\nParticipants who live in Japan, including the foreign students, should submit abstracts from the abstract submission page in Japanese<\/a>.<\/p>\n<\/div>\n\t\t<\/div>

\t\t\t

Abstract Submission guidelines
\uff08The 68th Annual Meeting of the Japanese Society of Pediatric Hematology \/ Oncology\uff09<\/h2>\n

1. Abstract Submission<\/h2>\n

April 1 (Wed), 2026 \u2013 May 20 (Wed), 2026, 12:00 PM (JST)<\/span><\/p>\n<\/div>\n\t\t<\/div>

\t\t\t

2. Application for Abstract<\/h2>\n

(Paper Presentation\/Poster Presentation)<\/span>
\nSelect the style of presentation, either Paper presentation or Poster presentation.
\nSelect an appropriate category from the following list.
\n

<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
001<\/th>\nALL<\/td>\n019<\/th>\nMiscellaneous Solid Tumors<\/td>\n<\/tr>\n
002<\/th>\nAML<\/td>\n020<\/th>\nDiagnostic Imaging<\/td>\n<\/tr>\n
003<\/th>\nLymphoma<\/td>\n021<\/th>\nHematopoietic Cell
Transplantation<\/td>\n<\/tr>\n
004<\/th>\nMyeloproliferative Disorder<\/td>\n022<\/th>\nSurgery<\/td>\n<\/tr>\n
005<\/th>\nMDS\/JMML<\/td>\n023<\/th>\nRadiotherapy<\/td>\n<\/tr>\n
006<\/th>\nAplastic Anemia<\/td>\n024<\/th>\nNovel Approach<\/td>\n<\/tr>\n
007<\/th>\nThrombosis and Hemostasis<\/td>\n025<\/th>\nSupportive Care<\/td>\n<\/tr>\n
008<\/th>\nPlatelet<\/td>\n026<\/th>\nLate Effect<\/td>\n<\/tr>\n
009<\/th>\nHLH\/LCH<\/td>\n027<\/th>\nPalliative Care<\/td>\n<\/tr>\n
010<\/th>\nMiscellaneous Hematological
Disorders<\/td>\n		028<\/th>\nSupport for children and their family<\/td>\n<\/tr>\n
011<\/th>\nBrain Tumor<\/td>\n029<\/th>\nEpidemiology\/Biostatistics<\/td>\n<\/tr>\n
012<\/th>\nNeuroblastoma<\/td>\n030<\/th>\nInternational Cooperation<\/td>\n<\/tr>\n
013<\/th>\nRenal Tumor<\/td>\n031<\/th>\nImmune Disorder<\/td>\n<\/tr>\n
014<\/th>\nLiver Tumor<\/td>\n032<\/th>\nPathology<\/td>\n<\/tr>\n
015<\/th>\nEwing Sarcoma<\/td>\n033<\/th>\nBasic Research for Solid Tumors<\/td>\n<\/tr>\n
016<\/th>\nRhabdomyosarcoma<\/td>\n034<\/th>\nVascular Malformation<\/td>\n<\/tr>\n
017<\/th>\nOsteosarcoma<\/td>\n035<\/th>\nSurvivorship<\/td>\n<\/tr>\n
018<\/th>\nGerm Cell Tumor<\/td>\n036<\/th>\nMiscellaneous<\/td>\n<\/tr>\n<\/table>\n

<\/div><\/p>\n<\/div>\n\t\t<\/div>

\t\t\t

3. Submission Guidelines<\/h2>\n
<\/p>\n\n\n\n\n\n
Language<\/th>\nEnglish<\/td>\n<\/tr>\n
Abstract Title<\/th>\n20 words including spaces<\/td>\n<\/tr>\n
Abstract Body N<\/th>\nNo longer than 1,600 characters, including spaces
(This roughly corresponds to 300\u2013350 words)<\/td>\n<\/tr>\n
No. of authors<\/th>\nMaximum 15 persons
(including first author and co-authors)<\/td>\n<\/tr>\n<\/table>\n

<\/div>\n